U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
198691198691Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or DidanosineCompletedNo Results AvailableHIV InfectionsDrug: Lamivudine|Drug: Stavudine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000838
198692198692A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsBiological: Varicella Virus Vaccine (Live)https://ClinicalTrials.gov/show/NCT00000837
198693198693A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)CompletedNo Results AvailableCytomegalovirus Retinitis|HIV InfectionsDrug: Sevirumabhttps://ClinicalTrials.gov/show/NCT00000836
198694198694A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion VaccineWithdrawnNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00000835
198695198695A Phase I Study of Methotrexate for HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: Lamivudine|Drug: Methotrexate|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000834
198696198696A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.CompletedNo Results AvailableHIV InfectionsDrug: Ribavirin|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000833
198697198697A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult VolunteersCompletedNo Results AvailableHIV InfectionsBiological: MF59|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00000832
198698198698Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI MonotherapyCompletedNo Results AvailableHIV InfectionsDrug: Lamivudine|Drug: Stavudine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000831
198699198699Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.CompletedNo Results AvailableHIV Infections|Pregnancyhttps://ClinicalTrials.gov/show/NCT00000830
198700198700A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected InfantsCompletedNo Results AvailableHIV Infections|Pneumococcal InfectionsBiological: Pneumococcal Vaccine, Polyvalent (23-valent)|Biological: Pneumococcal Conjugate Vaccine, Heptavalent|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00000829
198701198701Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With ZidovudineCompletedNo Results AvailableHIV Infections|Pregnancyhttps://ClinicalTrials.gov/show/NCT00000828
198702198702A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Anti-HIV Immune Serum Globulin (Human)https://ClinicalTrials.gov/show/NCT00000827
198703198703Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedNo Results AvailableBacterial Infections|Mycoses|HIV InfectionsDrug: Clarithromycin|Drug: Rifabutin|Drug: Sulfamethoxazole-Trimethoprim|Drug: Dapsone|Drug: Fluconazolehttps://ClinicalTrials.gov/show/NCT00000826
198704198704The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNo Results AvailableHIV InfectionsDrug: Aldesleukinhttps://ClinicalTrials.gov/show/NCT00000825
198705198705A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected PatientsTerminatedNo Results AvailableHIV InfectionsDrug: Lymphocytes, Activatedhttps://ClinicalTrials.gov/show/NCT00000824
198706198706A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 InfectionCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000823
198707198707A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T CellsCompletedNo Results AvailableHIV InfectionsDrug: Ritonavir|Biological: gp160 Vaccine (Immuno-AG)|Drug: Stavudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000822
198708198708Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Aldesleukinhttps://ClinicalTrials.gov/show/NCT00000821
198709198709A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral TherapyCompletedNo Results AvailableHIV InfectionsDrug: Aldesleukinhttps://ClinicalTrials.gov/show/NCT00000820
198710198710A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)CompletedNo Results AvailableHIV Infections|AIDS-Associated NephropathyDrug: Prednisonehttps://ClinicalTrials.gov/show/NCT00000819
198711198711Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.CompletedNo Results AvailableHIV InfectionsDrug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000818
198712198712The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected PatientsCompletedNo Results AvailableHIV Infections|Peripheral Nervous System DiseaseDrug: Amitriptyline hydrochloride|Drug: Amitriptyline hydrochloride placebo|Procedure: Point acupuncturehttps://ClinicalTrials.gov/show/NCT00000817
198713198713Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia ProphylaxisCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Sulfamethoxazole-Trimethoprimhttps://ClinicalTrials.gov/show/NCT00000816
198714198714A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials GroupCompletedNo Results AvailableHIV Infections|MeaslesBiological: Attenuvax|Biological: M-M-R-IIhttps://ClinicalTrials.gov/show/NCT00000815
198715198715A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV DiseaseCompletedNo Results AvailableHIV InfectionsDrug: Nevirapine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000814
198716198716A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult VolunteersCompletedNo Results AvailableHIV InfectionsBiological: ALVAC-HIV gp160MN (vCP125)|Biological: ALVAC-RG Rabies Glycoprotein (vCP65)|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00000813
198717198717A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 InfectionCompletedNo Results AvailableHIV InfectionsDrug: Thalidomidehttps://ClinicalTrials.gov/show/NCT00000812
198718198718A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive ChildrenCompletedNo Results AvailableBacterial Infections|Pneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Azithromycin|Drug: Atovaquone|Drug: Sulfamethoxazole-Trimethoprimhttps://ClinicalTrials.gov/show/NCT00000811
198719198719Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)CompletedNo Results AvailableHIV InfectionsDrug: Delavirdine mesylate|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000810
198720198720Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected WomenWithdrawnNo Results AvailableHIV Infections|HIV SeronegativityBiological: Aluminum hydroxide|Biological: QS-21|Biological: MN rsgp120/HIV-1https://ClinicalTrials.gov/show/NCT00000809

* Görseller ve İçerik tekif hakkına sahip olabilir